Results 91 to 100 of about 26,689 (268)

Plerixafor and G‐CSF Versus Placebo and G‐CSF in Moderately Mobilizing Patients With Multiple Myeloma to Optimize Hematopoietic Stem Cell Collection Results (OPTIMIZE) [PDF]

J Clin Apher
ABSTRACT Efficient collection of hematopoietic progenitor cells (HPCs) is essential for autologous stem cell transplantation (ASCT) in multiple myeloma (MM). Although plerixafor is routinely used in poor mobilizers, its role in patients with intermediate mobilization capacity remains unclear.
Nina W, Martin S, Andreas T, Martin K, Bianca H, Peter N, Konrad R, Nazanin S, Manuela B, Vera K, Sophia O, Beatrix K, Elvira K, Reinhard R, Werner R, Hermine A, Maria K, T. G.   +17 more
europepmc   +2 more sources

apheresis registry study on Wilson's disease

, 2016
Wilson's disease is a rare autosomal recessive genetic disorder that results in accumulation of copper in the liver, brain, cornea and kidney. Therapeutic plasma exchange (TPE) has been used to remove copper and provide a bridge to liver transplantation.
Kim, Haewon C, Wu, Yanyun, Chisa Yamada, Winters, Jeffrey L, Pham, Huy P, Huy P. Pham, Jeffrey L. Winters, Pagano, Monica B, Morgan, Shanna, Laura Cooling, Jan C. Hofmann, Jennifer Schneiderman, Yanyun Wu, Cooling, Laura, Haewon C. Kim, Monica B. Pagano, Edward C.C. Wong, Schneiderman, Jennifer, Schwartz, Joseph, Shanna Morgan, Hofmann, Jan C, Wong, Edward C C, Yamada, Chisa, Joseph Schwartz   +23 more
core   +1 more source

Assessing the financial resources required to establish convalescent plasma collection programmes across Europe in response to a pandemic

Transfusion, EarlyView.
Abstract Background During the COVID‐19 pandemic, convalescent plasma (CP) was investigated as a potential treatment. We assess the financial resources required to implement a COVID‐19 CP (CCP) programme and provide recommendations on how best to prepare for collection and use of CP in future pandemics.
Elizabeth A. Stokes, Abigail A. Lamikanra, David J. Roberts, Lise J. Estcourt, Pierre Tiberghien, Jose Leal   +5 more
wiley   +1 more source

Apheresis Medicine education in the United States of America: State of the discipline

, 2017
Apheresis Medicine is a medical discipline that involves a variety of procedures (based on the targeted component to be removed or collected), indications (therapeutic vs. donation), and personnel (operators, management, and medical oversight). Apheresis
Pagano, Monica B, Zantek, Nicole D, Wong, Edward CC, Wehrli, Gay, Cloutier, Darlene, Galvin Karr, Eileen, Andrzejewski, Chester, Wong, Edward C C, Winters, Jeffrey L, Lopez-Plaza, Ileana, Schwartz, Joseph, Wu, Yanyun   +11 more
core   +1 more source

Clinical performance and limitations of a vital sign‐based electronic automatic notification system for suspected transfusion reactions: A 6‐year experience

Transfusion, EarlyView.
Abstract Background Automated surveillance systems such as the electronic automatic notification system (EANS) have been introduced to improve recognition of adverse transfusion reactions (ATRs), but their long‐term sustainability and operational limitations remain incompletely defined. Study Design and Methods We conducted a 6‐year retrospective study
Young Ae Lim, Chorong Park, Jin Kim
wiley   +1 more source

Development of a Uniform Apheresis Case Report Form for Standardized Collection of Apheresis Data

Apheresis is performed worldwide for an increasing number of indications. The development of common data elements (CDE) for apheresis related areas may facilitate conduct of new research, enhance quality initiatives including benchmarking, and improve ...
Balogun, Rasheed A, Wu, Yanyun, Winters, Jeffrey L, Pederson, Thomas, Szczepiorkowski, Zbigniew M, Johnson, Andrew D, Burgstaler, Edwin, Chlebeck, Therese, Nellis, Marianne, Pavenski, Katerina, Armendariz, Tomas, Geile, Kira, Sanchez, Amber P, Collins, Laura, Witt, Volker, Thao, Mai, Schneiderman, Jennifer, Schwartz, Joseph, Zantek, Nicole D, Muthusamy, Amutha, Karam, Oliver, Ramesh, Vidhyalakshmi   +21 more
core   +1 more source

The lymphocyte function of allogeneic peripheral blood stem cell grafts is associated with relapse and cytomegalovirus reactivation

Transfusion, EarlyView.
Abstract Background Allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment primarily for hematological malignancies. Infections, relapse, and graft versus host disease (GvHD) are some of the most common adverse events following HSCT. We aimed to evaluate whether the lymphocyte function of the stem cell graft was associated with these ...
Anna Söderström, Tengyu Wang, Johan Törlén, Hannes Lindahl, Davide Valentini, Stephan Mielke, Klara Asplund Högelin, Rebecca Axelsson Robertson, Michael Uhlin   +8 more
wiley   +1 more source

Molecular Characterization of Mobilized Apheresis Hematopoietic Progenitor Cells Designated for Autologous Stem Cell Transplantation in Multiple Myeloma. [PDF]

EJHaem
ABSTRACT Introduction Multiple myeloma is the second most common malignancy of the lymphoid system and accounts for about 2% of cancer deaths. Treatment generally consists of chemotherapy and autologous stem cell transplantation. Clinical trial results are equivocal as to whether autologous stem cell transplantation in the treatment of multiple myeloma
Singh G, Kim K, Bollag RJ.
europepmc   +2 more sources

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

, 2019
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease ...
Wu, Yanyun, Aqui, Nicole, Rasheed A. Balogun, Laura Connelly‐Smith, Nicole Aqui, Anand Padmanabhan, Pham, Huy P., Nancy M. Dunbar, Erin Meyer, Klingel, Reinhard, Guest Editor: Joseph Schwartz, Padmanabhan, Anand, Reinhard Klingel, Volker Witt, Balogun, Rasheed A., Nicole D. Zantek, Dunbar, Nancy M., Huy P. Pham, Meyer, Erin, Zantek, Nicole D., Jennifer Schneiderman, Yanyun Wu, Witt, Volker, Schneiderman, Jennifer, Connelly-Smith, Laura, Schwartz, Joseph   +25 more
core   +1 more source

Challenges, Difficulties, and Delayed Diagnosis of Multiple Myeloma

Diagnostics
Background: Multiple myeloma (MM) is a heterogeneous plasma cell malignancy with non-specific symptoms and disease heterogeneity at clinical and biological levels.
Tugba Zorlu, Merve Apaydin Kayer, Nazik Okumus, Turgay Ulaş, Mehmet Sinan Dal, Fevzi Altuntas   +5 more
doaj   +1 more source